The following case reports produced by the Department of Tissue Viability at Grampian NHS, Aberdeen, were carried out to evaluate the performance of Mepitel One when used to treat a selection of patients with chronic wounds of varying aetiology, some in hard-to-dress areas, that were associated with significant comorbidities.
Supported by Molnlycke Healthcare
For the latest news and articles
© Copyright Omniamed Communications. All Rights Reserved
108 Cannon Street, London, EC4N 6EU. Registered in the United Kingdom
Free for all healthcare professionals
By clicking ‘Subscribe’, you are agreeing that the Wounds Group are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our privacy policy.
Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.
We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.
